Xanthohumol as an Adjuvant in the Treatment of Septic Shock
Xanthohumol as an Adjuvant in the Treatment of Septic Shock
Recruiting · NCT06225258 · Registry updated 2025-07-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Xanthohumol as an Adjuvant in the Treatment of Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, toxic shock syndrome | Recruiting | Phase 2 | 2025-07-04 | NCT06225258 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical University of Lublin | 14 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Intensive Care Unit, University Hospital No 4, | Lublin | Poland | 1 |